Skip to main content

Advertisement

SpringerLink
Log in

Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Osteosarcoma is the most common primary malignant bone tumor of childhood. Vascular endothelial growth factor (VEGF) expression has been implicated in tumor development and progression of osteosarcoma, but previous studies investigating the impact of VEGF expression on overall survival in patients with osteosarcoma report conflicting findings. A meta-analysis of published studies was performed. The pooled hazard ratio (HR) with its 95 % confidence interval (95 % CI) was used to assess the impact of VEGF expression on overall survival in patients with osteosarcoma. Nine studies with a total of 432 osteosarcoma patients were included into this meta-analysis. There was no between-study heterogeneity among those nine studies (I 2 = 0.0 %). Overall, high VEGF expression was obviously associated with poorer overall survival (HR = 1.68, 95 % CI 1.33–2.12, P < 0.001). Sensitivity analysis performed by excluding single study in turns showed the pooled estimate was stable. Egger’s test also did not suggest evidence for publication bias (P = 0.216). Therefore, this meta-analysis suggests that VEGF expression has an important impact on overall survival in patients with osteosarcoma and high VEGF expression is associated with poorer overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Grimer RJ. Surgical options for children with osteosarcoma. Lancet Oncol. 2005;6:85–92.

    Article  PubMed  Google Scholar 

  2. Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009;28:247–63.

    Article  PubMed  Google Scholar 

  3. Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 2010;60:222–43.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298–307.

    Article  PubMed  CAS  Google Scholar 

  5. Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L. Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer. Mol Aspects Med. 2011;32:88–111.

    Article  PubMed  CAS  Google Scholar 

  6. Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563–84.

    Article  PubMed  CAS  Google Scholar 

  7. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res. 2000;6:572–7.

    PubMed  CAS  Google Scholar 

  8. Jung ST, Moon ES, Seo HY, Kim JS, Kim GJ, Kim YK. Expression and significance of TGF-beta isoform and VEGF in osteosarcoma. Orthopedics. 2005;28:755–60.

    PubMed  Google Scholar 

  9. Bajpai J, Sharma M, Sreenivas V, Kumar R, Gamnagatti S, Khan SA, et al. VEGF expression as a prognostic marker in osteosarcoma. Pediatr Blood Cancer. 2009;53:1035–9.

    Article  PubMed  Google Scholar 

  10. Lin F, Zheng SE, Shen Z, Tang LN, Chen P, Sun YJ, et al. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma. Med Oncol. 2011;28:649–53.

    Article  PubMed  CAS  Google Scholar 

  11. Yang J, Yang D, Sun Y, Sun B, Wang G, Trent JC, et al. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer. 2011;117:4925–38.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  12. Rastogi S, Kumar R, Sankineani SR, Marimuthu K, Rijal L, Prakash S, et al. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study. Int Orthop. 2012;36:2315–21.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  18. Charity RM, Foukas AF, Deshmukh NS, Grimer RJ. Vascular endothelial growth factor expression in osteosarcoma. Clin Orthop Relat Res. 2006;448:193–8.

    Article  PubMed  CAS  Google Scholar 

  19. Chen GL, Lin HB, Wu XW, Li RY, Chen XH. The correlation between the level of serum vegf and bfgf with metastasis and prognosis of osteosarcoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011;27:1343–5.

    PubMed  CAS  Google Scholar 

  20. Lugowska I, Wozniak W, Klepacka T, Michalak E, Szamotulska K. A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma. Pediatr Blood Cancer. 2011;57:63–8.

    Article  PubMed  Google Scholar 

  21. Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21 Suppl 7:vii320–325.

    PubMed  Google Scholar 

  22. Korpi JT, Hagstrom J, Lehtonen N, Parkkinen J, Sorsa T, Salo T, et al. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol. 2011;20:e18–22.

    Article  PubMed  Google Scholar 

  23. Masrouha KZ, Khattab R, Tawil A, Abdallah A, Saghieh S, Haidar R, et al. A preliminary investigation of beta-hCG expression in patients with osteosarcoma. J Bone Joint Surg Br. 2012;94:419–24.

    Article  PubMed  CAS  Google Scholar 

  24. Chen Y, Zhang L, Pan Y, Ren X, Hao Q. Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer. Int J Mol Sci. 2012;13:13264–74.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  25. Guo JH, Zhu X, Li XT, Yang RJ. Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Chin J Cancer Res. 2012;24:36–43.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  26. Hong KD, Lee Y, Kim BH, Lee SI, Moon HY. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor c and vascular endothelial growth factor receptor 3, in colorectal cancer. Am Surg. 2013;79:198–204.

    PubMed  Google Scholar 

  27. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, et al. Microvessel density and vegf expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer. 2006;94:1823–32.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  28. Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin XQ, et al. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis. J Thorac Oncol. 2009;4:1094–103.

    Article  PubMed  Google Scholar 

  29. Chen M, Cai E, Huang J, Yu P, Li K. Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21:1126–34.

    Article  PubMed  CAS  Google Scholar 

  30. Liu L, Ma XL, Xiao ZL, Li M, Cheng SH, Wei YQ. Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev. 2012;13:3089–97.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

The authors declare no competing financial interests.

Author information

Authors and Affiliations

  1. Orthopedics Department, Fuzhou General Hospital of Nanjing Military, No. 156 West Second Ring Road, Fuzhou, Fujian, China

    Yanfeng Zhuang & Meiyang Wei

Authors
  1. Yanfeng Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meiyang Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meiyang Wei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhuang, Y., Wei, M. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis. Tumor Biol. 35, 1745–1749 (2014). https://doi.org/10.1007/s13277-014-1692-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1692-8

Keywords

Search

Navigation